Description
Composition, form of release and packaging
Film-coated tablets – 1 tablet:
- active substance: letrozole – 2.50 mg;
- excipients: lactose monohydrate – 50.00 mg, sodium carboxymethyl starch – 2.50 mg, colloidal silicon dioxide – 0.50 mg, microcrystalline cellulose – 28.00 mg, crospovidone – 4.00 mg, corn starch pregelatinised – 11.50 mg, magnesium stearate – 1.0 mg;
- film coating: “Opadray Y 1-7000” [hypromellose, titanium dioxide, macrogol (polyethylene glycol)] – 3.73 mg, iron oxide yellow dye – 0.27 mg.
- Film-coated tablets, 2.5 mg.
10 tablets each in a contoured cell pack made of polyvinylchloride film and aluminium foil.
3 contoured cell packs together with instructions for use are placed in a cardboard pack.
Description of dosage form
Round biconvex tablets covered with a yellow coloured film coating. On cross section the tablet core is white or white with yellowish tinge.
Pharmacotherapeutic group
Antitumour agent, estrogen synthesis inhibitor.
Reviews
There are no reviews yet.